Antipyretic drugs :: Consumers survey results of for 2 quarter of 2019

Consumers survey results of for 2 quarter of 2019 in category

Cold and Flu / Antipyretic drugs

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.	6	Панадол (GlaxoSmithKline)	19.35%	5

2.	4	Анальгін (Лубнифарм)	16.13%	4.17

2.	4	Колдрекс (GlaxoSmithKline)	16.13%	4.17

2.	1	Нурофєн (Reckitt Benckiser)	16.13%	4.17

2.	3	Фервекс (Bristol-Myers Squibb)	16.13%	4.17

6.	7	Анальгін (Pharmaceutical company “Zdorovya”)	12.90%	3.33

6.	5	Анальгін-Дарниця (Darnitsa)	12.90%	3.33

6.	5	Аспірин (Bayer)	12.90%	3.33

6.	~	Гриппостад (Nizhpharm)	12.90%	3.33

6.	5	Парацетамол (Arterium Corporation)	12.90%	3.33

11.	~	Antiflu (Bayer)	9.68%	2.50

11.	5	Аміцитрон (InterChem)	9.68%	2.50

11.	7	Антикатарал (Сперко Україна)	9.68%	2.50

11.	7	Грипаут (Wens Formulation)	9.68%	2.50

11.	7	Комбігрип (ORGANOSYN)	9.68%	2.50

16.	~	Грипмакс (Unipharm, Inc)	6.45%	1.67

16.	7	Мілістан (Mili Healthcare)	6.45%	1.67

16.	2	Німесил (Berlin-Chemie Menarini)	6.45%	1.67

16.	6	Найз (Nimesulid)	6.45%	1.67

16.	~	Парацетамол (Лубнифарм)	6.45%	1.67

16.	~	Парацетамол (сироп) (Борщагівський ХФЗ)	6.45%	1.67

16.	5	Парацетамол-Дарниця (Darnitsa)	6.45%	1.67

16.	6	Фармацитрон (Pharmascience)	6.45%	1.67

16.	~	Цитропак-Дарниця (Darnitsa)	6.45%	1.67

25.	7	Грипго (Gledpharm)	3.23%	0.83

25.	7	Грипомед (Red star)	3.23%	0.83

25.	7	Ефералган (Bristol-Myers Squibb)	3.23%	0.83

25.	6	Колдфлю Екстра (Genom Biotech)	3.23%	0.83

25.	6	Терафлю (Novartis OTC)	3.23%	0.83

25.	7	Цитрамон-М (Red star)	3.23%	0.83

–.	7	Імет (Berlin-Chemie Menarini)	0.00%	0

–.	7	Аскопар (Pharmaceutical company “Zdorovya”)	0.00%	0

–.		Аскофен Л (Лубнифарм)	0.00%	0

–.		Аскофен-Дарниця (Darnitsa)	0.00%	0

–.	7	Колдрін (Teva)	0.00%	0

–.		Копацил (Arterium Corporation)	0.00%	0

–.		Кофальгін (Борщагівський ХФЗ)	0.00%	0

–.		Кофан (Bosnalijek)	0.00%	0

–.		Німегезик (Alembic Chemical Works Company Ltd)	0.00%	0

–.		Налгезін (KRKA)	0.00%	0

–.		Пенталгін IC (InterChem)	0.00%	0

–.		Пенталгін-ICN (Фармстандарт-Лекарства)	0.00%	0

–.		Пенталгін-ФС (Фарма Старт)	0.00%	0

–.		Пиарон (Kusum Pharm)	0.00%	0

–.	7	Рапідол (Actavis)	0.00%	0

–.		Риніколд (Shreya Life Sciences)	0.00%	0

–.	7	Ринза (Johnson & Johnson)	0.00%	0

–.		Тринелл (Береш Фарма)	0.00%	0

–.	6	Упсарин Упса (Bristol-Myers Squibb)	0.00%	0

–.		Фармадол (Farmak)	0.00%	0

–.	7	Флюколд-N (Nabros Pharma)	0.00%	0

–.		Хелпекс (Movi Health GmbH)	0.00%	0

–.		Цефекон Н (Nizhpharm)	0.00%	0

–.	6	Цитрамон Екстра (Darnitsa)	0.00%	0

–.		Цитрамон У (Лубнифарм)	0.00%	0

–.		Цитрамон-Ф (Фітофарм)	0.00%	0

–.		~~Максиган (Unichem Laboratories)~~	~~0.00%~~	0

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2019, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.